Aprepitant (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Aprepitant drug offered from Glenmark Pharmaceuticals Inc., USA. This Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Aprepitant |
| SUBSTANCE NAME: | APREPITANT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-12 |
| END MARKETING DATE: | 0000-00-00 |
Aprepitant HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aprepitant from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2017-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-583_9a03e97e-ec9e-4e14-8b25-b7300fe93221 |
| PRODUCT NDC: | 68462-583 |
| APPLICATION NUMBER: | ANDA207777 |
Other APREPITANT Pharmaceutical Manufacturers / Labelers:
